Intellectual Property India Publishes Patent Application for N-Phenyl-3-(2,5-Dioxopyrrolidin-1-Yl)propanamide Derivatives And Similar Compounds As Dux4 Inhibitors For The Treatment Of E.g. Neuromuscular Disorders

MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617059242 A) filed by Altay Therapeutics, Inc. on May 09, 2026, for N-Phenyl-3-(2,5-Dioxopyrrolidin-1-Yl)propanamide Derivatives And Similar Compounds As Dux4 Inhibitors For The Treatment Of E.g. Neuromuscular Disorders.

Inventors include Ozes, Ali; and Latimer, Lee.

The application for the patent was published on June 26, 2026, under issue no. 26/2026.

Abstract: The present invention relates to compounds of formula (A) as DUX4 inhibitors for the treatment of e.g. neuromuscular disorders, inflammatory disorders, facioscapulohumeral muscular dystrophy, B-cell leukemia, sarcomas, solid cancers, rheumatoid arthritis, axial spondylarthritis, viral in...